دورية أكاديمية

Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study

التفاصيل البيبلوغرافية
العنوان: Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study
المؤلفون: Li, Yan-YanAff1, Aff2, Ge, Shuai-ShuaiAff1, Aff2, Huang, Yuan-HongAff1, Aff2, Xu, Ming-ZhuAff1, Aff2, Wan, Chao-LingAff1, Aff2, Tan, Kai-WenAff1, Aff2, Tao, Tao, Zhou, Hai-XiaAff1, Aff2, IDs41408024009823_cor8, Xue, Sheng-LiAff1, Aff2, IDs41408024009823_cor9, Dai, Hai-PingAff1, Aff2, IDs41408024009823_cor10
المصدر: Blood Cancer Journal. 14(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:20445385
DOI:10.1038/s41408-024-00982-3